BioCentury
ARTICLE | Financial News

Dauntless adds $25M to series A round

February 17, 2017 12:57 AM UTC

Dauntless Pharmaceuticals Inc. (San Diego, Calif.) raised $25 million in an extension of its series A round. New investor Canaan Partners joined existing investor Sofinnova Ventures in the round.

The extension brings the round's total to $32 million. Dauntless announced a $12 million series A round in 2015, but had drawn only $8 million prior to the extension, including $1 million in a promissory note that became part of the extension, according to VP of Business Development Karen Basbaum...

BCIQ Company Profiles

Dauntless Pharmaceuticals Inc.